Another concept that should be explored more is chronopharmacology since most targets for the treatment of MASLD (for example, thyroid hormone receptor, GLP-1, and FGF-21) are under circadian oscillation. Here, GCG is linked to metabolic dysfunction-associated steatotic liver disease.